The role of hyperuricemia and gout in kidney and cardiovascular disease.
NL Edwards - Cleveland Clinic journal of medicine, 2008 - europepmc.org
Elevated serum urate levels are recognized as leading to gouty arthritis, tophi formation, and
uric acid kidney stones. While serum urate elevations have long been associated with renal …
uric acid kidney stones. While serum urate elevations have long been associated with renal …
The role of hyperuricemia in vascular disorders
NL Edwards - Current opinion in rheumatology, 2009 - journals.lww.com
… The following disclosure was not indicated in the recent article by Edwards . Dr Edwards
has received consulting fees from Savient Pharmaceuticals, Inc., and Takeda Pharmaceuticals, …
has received consulting fees from Savient Pharmaceuticals, Inc., and Takeda Pharmaceuticals, …
Vasculitis associated with malignancy experience with 13 patients and literature review
JM GREER, S LONGLEY, NL EDWARDS… - Medicine, 1988 - journals.lww.com
Methods We identified and investigated 13 patients with lympho-or myeloproliferative
disorders and associated vasculitis seen between 1970 and 1987. We performed the following …
disorders and associated vasculitis seen between 1970 and 1987. We performed the following …
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …
… Edwards has received consultant fees, speaking fees, and/or honoraria (less than $10,000
each) from Savient, Takeda, Ardea, and Regeneron, and (more than $10,000) from Novartis, …
each) from Savient, Takeda, Ardea, and Regeneron, and (more than $10,000) from Novartis, …
[PDF][PDF] 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
…, M Brown, H Choi, NL Edwards… - Arthritis & …, 2015 - Wiley Online Library
… Edwards has received consulting fees, speaking fees, and/or honoraria from AstraZeneca,
Crealta, CymaBay, and Takeda (less than $10,000 each). Dr. Lioté has received consulting …
Crealta, CymaBay, and Takeda (less than $10,000 each). Dr. Lioté has received consulting …
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis
In response to a request for proposal from the American College of Rheumatology (ACR), our
group was charged with developing nonpharmacologic and pharmacologic guidelines for …
group was charged with developing nonpharmacologic and pharmacologic guidelines for …
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials
JS Sundy, HSB Baraf, RA Yood, NL Edwards… - Jama, 2011 - jamanetwork.com
Context Patients with chronic disabling gout refractory to conventional urate-lowering
therapy need timely treatment to control disease manifestations related to tissue urate crystal …
therapy need timely treatment to control disease manifestations related to tissue urate crystal …
A cooperative interaction between NF‐kappa B and Sp1 is required for HIV‐1 enhancer activation.
ND Perkins, NL Edwards, CS Duckett… - The EMBO …, 1993 - embopress.org
The human immunodeficiency virus (HIV‐1) long terminal repeat (LTR) contains two binding
sites for NF‐kappa B in close proximity to three binding sites for the constitutive transcription …
sites for NF‐kappa B in close proximity to three binding sites for the constitutive transcription …
'Rhupus' syndrome
RS Panush, NL Edwards, S Longley… - Archives of Internal …, 1988 - jamanetwork.com
• Occasionally patients with overlapping features of rheumatoid arthritis (RA) and systemic
lupus erythematosus (SLE), termed "rhupus," have been encountered. We wanted to …
lupus erythematosus (SLE), termed "rhupus," have been encountered. We wanted to …
Is running associated with degenerative joint disease?
RS Panush, C Schmidt, JR Caldwell, NL Edwards… - Jama, 1986 - jamanetwork.com
Little information is available regarding the long-term effects, if any, of running on the
musculoskeletal system. We therefore compared the prevalence of degenerative joint disease …
musculoskeletal system. We therefore compared the prevalence of degenerative joint disease …